---
title: "New Heaven Chemicals & Industries Ltd (524484) — Share Price, Financials & Analysis"
symbol: "524484"
company: "New Heaven Chemicals & Industries Ltd"
canonical: "https://tapetide.com/stocks/524484"
isin: "INE358P01012"
bse_code: "524484"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:38:31.052Z"
---

# New Heaven Chemicals & Industries Ltd (524484)

Canonical page: https://tapetide.com/stocks/524484

## Company

- **BSE Code:** 524484
- **ISIN:** INE358P01012
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2014-03-27
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** transmedicare.co.in

## About

Trans Medicare Limited is engaged in the manufacturing of pharmaceutical products.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -50% | 12% | -6% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.04 | 0.02 | 0.01 | 0.11 | 0.04 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | 0.12 |
| Operating Profit | -0.04 | -0.02 | -0.01 | -0.11 | -0.04 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.07 | -0.05 | -0.04 | -0.14 | -0.05 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.07 | -0.05 | -0.04 | -0.14 | -0.04 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| EPS in Rs | -0.14 | -0.1 | -0.08 | -0.27 | -0.08 | -0.02 | -0.02 | -0.08 | -0.02 | -0.02 | -0.02 | -0.23 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 3.03 | 0.05 | 0.05 | 0.08 | 0.41 | 0.17 | 0.2 | 0.11 | 0.08 | 0.15 |
| Operating Profit | -3.03 | -0.05 | -0.05 | -0.08 | -0.41 | -0.17 | -0.2 | -0.11 | -0.08 | -0.15 |
| Other Income | 5.81 | 0 | 0 | 0 | 0 | 0 | -1.48 | 0 | 0 | 0 |
| Interest | 3.34 | 2.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.03 | 0.02 | 0 |
| Profit before tax | -0.56 | -2.82 | -0.05 | -0.08 | -0.41 | -0.17 | -1.72 | -0.14 | -0.1 | -0.15 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | -0.56 | -2.82 | -0.05 | -0.08 | -0.41 | -0.17 | -1.73 | -0.14 | -0.1 | -0.15 |
| EPS in Rs | -1.09 | -5.47 | -0.1 | -0.16 | -0.79 | -0.33 | -3.35 | -0.27 | -0.19 | -0.29 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 |
| Reserves | -18.39 | -18.95 | -24.39 | -24.43 | -20.72 | -21.12 | -21.29 | -23.51 | -10.74 | -10.85 |
| Borrowings | 19.07 | 19.53 | 24.96 | 25 | 21.28 | 21.29 | 21.46 | 21.62 | 8.81 | 8.89 |
| Other Liabilities | 0.72 | 0.72 | 0.72 | 0.72 | 0.73 | 0.01 | 0.01 | 0.03 | 0.03 | 0.05 |
| Total Liabilities | 6.49 | 6.39 | 6.38 | 6.38 | 6.45 | 5.34 | 5.34 | 3.3 | 3.26 | 3.25 |
| Fixed Assets | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 0.32 | 0.28 | 0.26 |
| CWIP | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.01 | 0.01 | 0.01 |
| Investments | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
| Other Assets | 1.89 | 1.79 | 1.78 | 1.78 | 1.85 | 0.74 | 0.74 | 0.02 | 0.02 | 0.03 |
| Total Assets | 6.49 | 6.39 | 6.38 | 6.38 | 6.45 | 5.34 | 5.34 | 3.3 | 3.26 | 3.25 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.07 | -0.5 | -0.06 | -0.05 | -0.09 | -0.05 | -0.17 | -0.16 | -0.1 | -0.08 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0.07 | 0.5 | 0.06 | 0.05 | 0 | 0.01 | 0.16 | 0.16 | 0.1 | 0.08 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0.06 | -0.04 | -0.01 | -0.01 | 0 | 0 |
| Free Cash Flow | -0.07 | -0.5 | -0.06 | -0.05 | -0.09 | -0.05 | -0.17 | -0.16 | -0.1 | -0.08 |
| CFO/OP | 58 | 16 | 120 | 100 | 112 | 12 | 100 | 80 | 91 | 100 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROCE % | — | -2.1 | — | -0.88 | -1.41 | -7.42 | -3.19 | -5.58 | -4.31 | -3.11 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 |
| --- | --- | --- |
| Promoters | 25.59% | 25.59% |
| Public | 74.41% | 74.41% |
| No. of Shareholders | 15514 | 15506 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 25.59% | 25.59% | 25.59% | 25.59% | 25.59% | 25.59% | 25.59% | 25.59% |
| Public | 74.41% | 74.41% | 74.41% | 74.41% | 74.41% | 74.41% | 74.41% | 74.41% |
| No. of Shareholders | 15516 | 15516 | 15513 | 15514 | 15512 | 15512 | 15508 | 15506 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 7 / 4 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 253.51 | Sell |
| EMA (10) | 251.45 | Sell |
| SMA (20) | 257.89 | Sell |
| EMA (20) | 250.84 | Sell |
| SMA (50) | 234.8 | Buy |
| EMA (50) | 243.37 | Buy |
| SMA (100) | 238.18 | Buy |
| EMA (100) | 242.7 | Buy |
| SMA (200) | 254.8 | Sell |
| EMA (200) | 245.78 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.02 | Neutral |
| MACD (12,26,9) | 3.1 | Sell |
| Stochastic (14,3,3) | 13.7 | Buy |
| ADX (14) | 18.08 | Neutral |
| Williams %R (14) | -93.43 | Buy |
| ATR (14) | 14.24 | High Volatility |
| ROC (12) | -6.77 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 44.95 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 6 Oct 2025 - Confirms compliance with SEBI Regulations 6(1) and 7(1) for quarter ended September 30, 2025. | [Compliance Status Of Regulation 6 (1) And 7(1) Of SEBI (LODR) Regulations, 2015, As Amended, For The Quarter Ended September 30, 2025 6 Oct 2025 - Confirms compliance with SEBI Regulations 6(1) and 7(1) for quarter ended September 30, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d870d93b-084e-414e-96e0-635615ae018b.pdf) |
| 29 Jun 2018 - The members of the Company had passed Special Resolution approving the change in name of the Company from 'TRANS MEDICARE LIMITED' to 'NEW HEAVEN CHEMICALS … | [Change in name of the Company 29 Jun 2018 - The members of the Company had passed Special Resolution approving the change in name of the Company from 'TRANS MEDICARE LIMITED' to 'NEW HEAVEN CHEMICALS …](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D7F505E6_137C_4B9A_9A3E_72FBEADC48B6_150558.pdf) |
| 29 Jun 2018 - The members of the Company had passed Special Resolution approving the change in name of the Company from 'TRANS MEDICARE LIMITED' to 'NEW HEAVEN CHEMICALS … | [Change in name of the Company 29 Jun 2018 - The members of the Company had passed Special Resolution approving the change in name of the Company from 'TRANS MEDICARE LIMITED' to 'NEW HEAVEN CHEMICALS …](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/6/D7F505E6_137C_4B9A_9A3E_72FBEADC48B6_150558.pdf) |
| 14 Oct 2025 - Scheme effective Oct 14, 2025; Record Date Oct 28; Yaari shares issued 294/100 (fully), 162/100 (partly paid 55%). | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 14 Oct 2025 - Scheme effective Oct 14, 2025; Record Date Oct 28; Yaari shares issued 294/100 (fully), 162/100 (partly paid 55%).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b9cb6ff-f040-4a6e-b3aa-194b3cdc2095.pdf) |
| 10 Oct 2025 - CRISIL ESG assigned "Crisil ESG 52" to Dhani; unsolicited rating based on public data (Oct 10, 2025). | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - ESG Rating 10 Oct 2025 - CRISIL ESG assigned "Crisil ESG 52" to Dhani; unsolicited rating based on public data (Oct 10, 2025).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0a366e05-468a-42ee-a3ef-2611b2151211.pdf) |
| 10 Oct 2025 - Certificates confirming dematerialization/rematerialization details furnished for quarter ended Sept 30, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct 2025 - Certificates confirming dematerialization/rematerialization details furnished for quarter ended Sept 30, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1218195-4dfa-46e7-b331-75bd29eff653.pdf) |
| — | [Corporate Action-Amalgamation/ Merger / Demerger 14 Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9128c7d-2532-4e2e-87d2-0277f5e85e9b.pdf) |
| — | [Standalone Financial Results, Auditors Report for March 31, 2018 21 Jun 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59AB8B52_95DA_41C1_A454_66A2740BDBFE_144847.pdf) |
| — | [Standalone Financial Results, Auditors Report for March 31, 2018 21 Jun 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/6/59AB8B52_95DA_41C1_A454_66A2740BDBFE_144847.pdf) |
| — | [Financial Results For The Year Ended 31St March,2018 30 May 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5e135b9-b6a6-45c6-bb0e-50cf42ea97b0.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_2178_IBSEC_2012_2013_01102013154531.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ac59348-340c-4cbd-8599-872d827128e0.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0cefb46-08d1-48a7-8a04-87f40e8b1458.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7df53c32-4ff8-4c38-9596-2dbee85bd7fb.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/76375532960.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/70272532960.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/65721532960.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/5329600319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/5329600318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/532960/5329600317.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/78cd0578-ba9e-465b-9e47-e1e7c9ab2573.pdf) |
| Jun 2022 | [Concall - Jun 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9da39dd8-0793-43b8-98a0-4fcee72df287.pdf) |
| Dec 2020 | [Concall - Dec 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b62d9406-6287-4010-a3e0-192ea87dbf4d.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:38:31.052Z.